Evidence map›Paper›PMID 24963632›Full record

ArticlePloS one2014

Involvement of plasmalogens in post-natal retinal vascular development.

Sarah Saab, Bénédicte Buteau, Laurent Leclère, Alain M Bron, Catherine P Creuzot-Garcher, Lionel Bretillon, Niyazi Acar

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Unusual Presentation ofMovement disorders clinical practice · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Reduction of Ether-Type Glycerophospholipids, Plasmalogens, by NF-κB Signal Leading to Microglial Activation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  13. Peroxisomes in brain development and function.Biochimica et biophysica acta · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Sarah SaabCNRS, UMR6265 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; INRA, UMR1324 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Université de Bourgogne, UMR Centre des Sciences du Goût et de l'Alimentation, Dijon, France.
Bénédicte ButeauCNRS, UMR6265 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; INRA, UMR1324 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Université de Bourgogne, UMR Centre des Sciences du Goût et de l'Alimentation, Dijon, France.
Laurent LeclèreCNRS, UMR6265 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; INRA, UMR1324 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Université de Bourgogne, UMR Centre des Sciences du Goût et de l'Alimentation, Dijon, France.
Alain M BronCNRS, UMR6265 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; INRA, UMR1324 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Université de Bourgogne, UMR Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Department of Ophthalmology, University Hospital, Dijon, France.
Catherine P Creuzot-GarcherCNRS, UMR6265 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; INRA, UMR1324 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Université de Bourgogne, UMR Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Department of Ophthalmology, University Hospital, Dijon, France.
Lionel BretillonCNRS, UMR6265 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; INRA, UMR1324 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Université de Bourgogne, UMR Centre des Sciences du Goût et de l'Alimentation, Dijon, France.
Niyazi AcarCNRS, UMR6265 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; INRA, UMR1324 Centre des Sciences du Goût et de l'Alimentation, Dijon, France; Université de Bourgogne, UMR Centre des Sciences du Goût et de l'Alimentation, Dijon, France.
Université de Bourgogne · FRCentre des Sciences du Goût et de l'Alimentation · FRCentre National de la Recherche Scientifique · FRMaison des Sciences de l’Homme de Dijon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveProper development of retinal blood vessels is essential to ensure sufficient oxygen and nutrient supplies to the retina. It was shown that polyunsaturated fatty acids (PUFAs) could modulate factors involved in tissue vascularization. A congenital deficiency in ether-phospholipids, also termed "plasmalogens", was shown to lead to abnormal ocular vascularization. Because plasmalogens are considered to be reservoirs of PUFAs, we wished to improve our understanding of the mechanisms by which plasmalogens regulate retinal vascular development and whether the release of PUFAs by calcium-independent phospholipase A2 (iPLA2) could be involved. METHODS AND

resultsBy characterizing the cellular and molecular steps of retinal vascular development in a mouse model of plasmalogen deficiency, we demonstrated that plasmalogens modulate angiogenic processes during the early phases of retinal vascularization. They influence glial activity and primary astrocyte template formation, endothelial cell proliferation and retinal vessel outgrowth, and impact the expression of the genes involved in angiogenesis in the retina. These early defects led to a disorganized and dysfunctional retinal vascular network at adult age. By comparing these data to those obtained on a mouse model of retinal iPLA2 inhibition, we suggest that these processes may be mediated by PUFAs released from plasmalogens and further signalling through the angiopoietin/tie pathways.

conclusionsThese data suggest that plasmalogens play a crucial role in retinal vascularization processes.

Indexed as

AcyltransferasesAnimalsAnimals, NewbornAstrocytesBiomarkersCells, CulturedElectroretinographyEndothelium, VascularFatty Acids, UnsaturatedFemaleGene Expression ProfilingGroup VI Phospholipases A2Immunoenzyme TechniquesMaleMiceMice, Inbred C57BLAcyltransferasesBiomarkersFatty Acids, Unsaturatedglycerone-phosphate O-acyltransferaseGroup VI Phospholipases A2Pla2g6 protein, mousePlasmalogensRNA, Messenger

Identifiers

PMID24963632
PMCPMC4071069
OpenAlexW2015768321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.